Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-27

Clinical Trial Update: PMP-300E (Smart Watch): Portable Monitoring Device Study [Phase 3]

View source ↗

Summary

A Phase 3 study of the PMP-300E portable monitoring device for obstructive sleep apnea has completed, with results posted in January 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PMP-300E

Snippet

Sponsor: Stanford University | Conditions: Obstructive Sleep Apnea | Phase 3 | Status: COMPLETED | Results posted: 2017-01-27